20
Participants
Start Date
July 31, 2011
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
ranibizumab
0.5mg intravitreal injection, monthly for 12 months, or until BCVA returns to pre-wet AMD baseline.
Medical Center Ophthalmology Associates, San Antonio
Shiley Eye Center, UCSD, La Jolla
California Retina Consultants, Santa Barbara
California Retina Consultants, Bakersfield
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of California, San Diego
OTHER